GL1X · GenesisL1 explorer

MolNFT v1 · #51313 · protein

Crystallographic analysis of upper axial ligand substitutions in cobalamin bound to transcobalamin

2V3N · Transcobalamin-2: “Crystallographic analysis of upper axial ligand substitutions in cobalamin bound to transcobalamin”. X-ray diffraction, 3 ligands (B12, CL, CYN), 5 pockets (best druggability 0.72). MolNFT v1 #51313 on GenesisL1…

PDB
2V3N
Type
protein
Length
405 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcobalamin-2
UniProt
Q9XSC9
Ligands
B12, CL, CYN
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATranscobalamin-2protein40547% helix, 13% strandQ9XSC9

Ligands and binding sites

  • B12 · Cobalamin · ligand · chains A
  • CL · Chloride ion · ion · 3 copies · chains A
  • CYN · Cyanide ion · ion

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19100.720.7655B12, CYN, CL
21710.500.7829empty
3950.480.8124empty
4980.390.7623empty
5850.320.7316empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 2V3N · Crystallographic analysis of upper axial ligand substitutions in cobalamin bound to… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9XSC9 · AlphaFold monomer V2.0 prediction for transcobalamin-2 (Q9XSC9) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.